Smoke inhalation injury (SII) dramatically elevates burn patient mortality. Although N6-methyladenosine (m6A) methylation is emerging as a central epitranscriptomic regulator of lung inflammation and injury, its specific involvement in SII remains unknown. Using an in vivo mouse SII model and smoke extract-treated MLE-12 cells, we show that smoke exposure downregulates the m6A writer-complex component WTAP and reduces global m6A methylation. WTAP knockdown attenuates epithelial inflammation, apoptosis, and STAT3 activation. Integrating transcriptomics with weighted gene co-expression network analysis (WGCNA) and MeRIP-qPCR, we identify pIgR as a downstream target: WTAP modifies m6A methylation within the 756/772 region of pIgR mRNA, and its knockdown prolongs pIgR mRNA half-life and elevates pIgR expression. pIgR silencing reverses the protection conferred by WTAP knockdown. These findings define a WTAP/m6A/pIgR axis that shapes the early epithelial response to smoke inhalation and identifies WTAP as a candidate therapeutic target for SII.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: